Targeting Melanoma Cells with Human High Molecular Weight-Melanoma Associated Antigen-Specific Antibodies Elicited by a Peptide Mimotope: Functional Effects, The Journal of Immunology, vol.176, issue.10, pp.6046-6054, 2006. ,
DOI : 10.4049/jimmunol.176.10.6046
Adoptive immunotherapy for cancer: building on success, Nature Reviews Immunology, vol.115, issue.5, pp.383-393, 2006. ,
DOI : 10.1038/nri1842
Cytotoxic T cell induction against human malignant melanoma cells using HLA- A24-restricted melanoma peptide cocktail, Anticancer Res, vol.24, pp.571-577, 2004. ,
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3, Proceedings of the National Academy of Sciences, vol.98, issue.18, 2001. ,
DOI : 10.1073/pnas.161260098
Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide, The Journal of Immunology, vol.171, issue.9, pp.4893-4897, 2003. ,
DOI : 10.4049/jimmunol.171.9.4893
Immune responses in the draining lymph nodes against cancer: Implications for immunotherapy, Cancer and Metastasis Reviews, vol.10, issue.1, pp.233-242, 2006. ,
DOI : 10.1007/s10555-006-8503-7
Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity, Cancer Gene Therapy, vol.268, issue.12, pp.963-972, 2005. ,
DOI : 10.1038/sj.cgt.7700861
Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, issue.11, pp.991-998, 2002. ,
DOI : 10.1038/ni1102-991
Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules, Cancer Gene Therapy, vol.11, issue.7, pp.497-507, 2004. ,
DOI : 10.1038/sj.cgt.7700708
Melphalan and Other Anticancer Modalities Up-Regulate B7-1 Gene Expression in Tumor Cells, The Journal of Immunology, vol.164, issue.12, pp.6230-6236, 2000. ,
DOI : 10.4049/jimmunol.164.12.6230
5-aza- 29-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications, Clin Cancer Res, vol.8, pp.2690-2695, 2002. ,
Posttranslational modifications of the C-terminal region of the rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins, Oncogene, vol.6, pp.515-522, 1991. ,
Inhibition of Ras and Related G-Proteins As a Therapeutic Strategy for Blocking Malignant Glioma Growth, Neurosurgery, vol.43, issue.1, pp.124-131, 1998. ,
DOI : 10.1097/00006123-199807000-00081
Farnesylated RhoB Prevents Cell Cycle Arrest and Actin Cytoskeleton Disruption Caused by the Geranylgeranyltransferase I Inhibitor GGTI-298, Cell Cycle, vol.1, issue.6, pp.430-437, 2002. ,
DOI : 10.4161/cc.1.6.272
Selective inhibition of cancer cell invasion by a geranylgeranyltransferase-I inhibitor, Clinical and Experimental Metastasis, vol.20, issue.6, pp.561-567, 2003. ,
DOI : 10.1023/A:1025898316728
In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I, Molecular Cancer Therapeutics, vol.8, issue.5, pp.1218-1226, 2009. ,
DOI : 10.1158/1535-7163.MCT-08-1122
Differential Expression of MART-1, Tyrosinase, and SM5-1 in Primary and Metastatic Melanoma, The American Journal of Dermatopathology, vol.27, issue.5, pp.401-406, 2005. ,
DOI : 10.1097/01.dad.0000180076.17932.ee
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunology, Immunotherapy, vol.175, issue.4, pp.515-526, 2007. ,
DOI : 10.1007/s00262-006-0204-0
Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells, Cancer Res, vol.61, pp.1095-1099, 2001. ,
Very Early (VEA) and Very Late (VLA) Activation Antigens have Distinct Functions in T Lymphocyte Activation, Immunological Reviews, vol.1988, issue.1, pp.153-176, 1989. ,
DOI : 10.1084/jem.165.6.1725
Cytokine production by peripheral lymphocytes in melanoma, Eur Cytokine Netw, vol.16, pp.47-55, 2005. ,
Relationship between CD107a expression and cytotoxic activity, Cellular Immunology, vol.254, issue.2, pp.149-154, 2009. ,
DOI : 10.1016/j.cellimm.2008.08.007
Expression of the co-stimulatory molecule B7 on melanoma cells, International Journal of Cancer, vol.128, issue.4, pp.527-532, 1994. ,
DOI : 10.1002/ijc.2910580413
Statins Stimulate In Vitro Membrane FasL Expression and Lymphocyte Apoptosis through RhoA/ROCK Pathway in Murine Melanoma Cells, Neoplasia, vol.9, issue.12, pp.1078-1090, 2007. ,
DOI : 10.1593/neo.07727
T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals, The Journal of Experimental Medicine, vol.59, issue.5, 1999. ,
DOI : 10.1097/00002371-199601000-00009